Abstract:Non-obese diabetes (NOD) mice are an established, spontaneous model of type 1 diabetes in which diabetes develops through insulitis. Using next-generation sequencing, coupled with pathway analysis, the molecular fingerprint of early insulitis was mapped in a cohort of mice ranging from 4 to 12 weeks of age. The resulting dynamic timeline revealed an initial decrease in proliferative capacity followed by the emergence of an inflammatory signature between 6 and 8 weeks that increased to a regulatory plateau between 10 and 12 weeks. The inflammatory signature is identified by the activation of central immunogenic factors such as Infg, Il1b , and Tnfa , and activation of canonical inflammatory signaling. Analysis of the regulatory landscape revealed the transcription factor Atf3 as a potential novel modulator of inflammatory signaling in the NOD islets. Furthermore, the Hedgehog signaling pathway correlated with Atf3 regulation, suggesting that the two play a role in regulating islet inflammation; however, further studies are needed to establish the nature of this connection.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to dynamically depict the molecular characteristics of islets in non - obese diabetic (NOD) mice during the age of 4 to 12 weeks through next - generation sequencing (NGS) and pathway analysis, in order to reveal the occurrence mechanism of early insulitis. Specifically, the paper attempts to solve the following problems: 1. **Changes in islet proliferation ability**: Study the changes in the proliferation ability of islet cells in NOD mice during the age of 4 to 6 weeks, and the impact of this change on subsequent islet function. 2. **Emergence of inflammatory signals**: Explore the emergence of inflammatory signals in islets during the age of 6 to 8 weeks and their contribution to the development of isletitis. 3. **Maintenance and amplification of inflammatory signals**: Analyze the maintenance and amplification process of inflammatory signals during the age of 8 to 12 weeks, and how these changes affect the function and structure of islets. 4. **The role of Atf3 in inflammation**: Identify the role of Atf3 as a potential new inflammatory signal regulator in the islets of NOD mice, and explore its relationship with core immune factors (such as Ifng, Il1b, Tnf and Ccl2). 5. **The role of Hedgehog signaling pathway**: Study the potential role of Hedgehog signaling pathway in Atf3 regulation, and how this pathway participates in the development of islet inflammation. ### Main findings 1. **Decline in proliferation ability**: During the age of 4 to 6 weeks, the proliferation ability of islet cells in NOD mice decreased significantly. 2. **Emergence of inflammatory signals**: During the age of 6 to 8 weeks, strong inflammatory signals emerged in islets, manifested as a significant up - regulation of key immune factors (such as Ifng, Il1b, Tnf and Ccl2). 3. **Maintenance and amplification of inflammatory signals**: During the age of 8 to 10 weeks, the inflammatory signals were further enhanced, but reached a stable level during the age of 10 to 12 weeks. 4. **Regulatory role of Atf3**: Atf3 was significantly up - regulated during the age of 6 to 8 weeks, and may participate in the early stage of islet inflammation by promoting the expression of core immune factors through a positive feedback loop. 5. **Association of Hedgehog signaling pathway**: Key members of the Hedgehog signaling pathway were significantly up - regulated in 12 - week - old NOD mice, suggesting that this pathway may be related to the regulation of Atf3, but the specific mechanism still needs further study. ### Conclusion This study reveals the molecular mechanism of the early occurrence of isletitis through dynamic analysis of transcriptome changes in islets of NOD mice. In particular, Atf3, as a potential new inflammatory signal regulator, may play an important role in the early stage of islet inflammation. However, the specific role of Hedgehog signaling pathway in Atf3 regulation still needs further verification. These findings provide a new perspective for understanding the pathogenesis of type 1 diabetes and may provide clues for the development of new treatment strategies.

Molecular profiling of NOD mouse islets reveals a novel regulator of insulitis onset

Network approach reveals preferential T-cell and macrophage association with α-linked β-cells in early stage of insulitis in NOD mice

NOD alleles at Idd1 and Idd2 loci drive exocrine pancreatic inflammation

Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene

Remodeling of the innervation of pancreatic islets accompanies insulitis preceding onset of diabetes in the NOD mouse

Differential action of TIGIT on islet and peripheral nerve autoimmunity in the NOD mouse

Mathematical modeling of type 1 diabetes in the NOD mouse: separating incidence and age of onset

Insulin-dependent diabetes in the NOD mouse model. I. Detection and characterization of autoantibody bound to the surface of pancreatic beta cells prior to development of the insulitis lesion in prediabetic NOD mice

The NOD Mouse Beyond Autoimmune Diabetes

Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes

The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice

Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 Diabetes.

The type 1 diabetes susceptibility locus Idd5 favours robust neonatal development of highly autoreactive regulatory T cells in the NOD mouse

Tissue-specific Differences in the Development of Insulin Resistance in a Mouse Model for Type 1 Diabetes.

De novo germline mutation in the Dual Specificity Phosphatase 10 gene accelerates autoimmune diabetes in Non-Obese Diabetic (NOD) mice

Contribution of Different Mechanisms to Pancreatic Beta-cell Hyper-secretion in Non-obese Diabetic (NOD) Mice During Pre-diabetes

Modulation of Autoimmune Diabetes by N-ethyl-N-nitrosourea- Induced Mutations in Non-Obese Diabetic Mice

Mutual modulation of gut microbiota and the immune system in type 1 diabetes models

Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis

Nucleotide-binding Oligomerization Domain-Containing Protein 2 (nod2) Modulates T1DM Susceptibility by Gut Microbiota.

Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model.